USPTO serial 76434045
AMRAD
Reviewed by CopyMark Law Group
Reg. 2852572Status 710
- Filing date
- Status date
- Registration date
- Jun 15, 2004
- Examiner
- JOHNSON, AISHA CLARKE
- Law office
- POST REGISTRATION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with AMRAD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Richmad, Victoria, 3121, AU
Richmad, Victoria, 3121, AU
Richmad, Victoria, 3121, AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
TODD A. HARDY
TODD A HARDY BIRCH STEWART KOLASCH & BIRCH LLPPO BOX 747FALLS CHURCH, VA 22040-0747UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical preparations for scientific and research use, namely, proteinaceous reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA; reagents for scientific or medical research use, namely, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro and for the expression, isolation and detection of recombination; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use in detecting auto immune disease, microbial disease, protein levels, genetic abnormalities, and pathogens | SECTION 8 - CANCELLED | — |
| 005 | Medical and clinical medical reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro; pharmaceutical preparation for human and veterinary use in the treatment of blood disorders, viral disease and nervous system dysfunction, cancer, bone disease, liver disease, cardiac disorders, infertility, pregnancy disorders, and inflammation; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology | SECTION 8 - CANCELLED | — |
| 042 | Product research and development in the field of drug discovery; research and development for new products for others in the field of drug discovery; medical and scientific research, namely, * conducting clinical trials; biotechnology * consultation and research; pharmaceutical drug development services | SECTION 8 - CANCELLED | — |
| 044 | Medical testing; pharmaceutical advice | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AMRAD Corporation Limited
- Other trademarks owned by AMRAD Corporation Limited
- Other trademarks owned by AMRAD Corporation Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AMRAD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 21, 2011 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 12, 2004 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 23, 2004 | AMD7 | SEC 7 REQUEST FILED | — |
| Sep 23, 2004 | PAPER RECEIVED | — | |
| Jun 15, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 23, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 3, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 9, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2003 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Oct 27, 2003 | CFIT | CASE FILE IN TICRS | — |
| Sep 29, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2003 | PAPER RECEIVED | — | |
| May 21, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Apr 29, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2003 | PAPER RECEIVED | — | |
| Apr 9, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 3, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 29, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2002 | DOCK | ASSIGNED TO EXAMINER | — |